379 results in Exploration of Targeted Anti-tumor Therapy
Most Viewed
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Predictive value of 8-hydroxy-2′-deoxyguanosine and 8-nitroguanine production in radiation-induced skin damage after postoperative breast cancer radiotherapy
Emmanouil K. Verigos ... Dimitrios T. Trafalis
Published: September 22, 2025 Explor Target Antitumor Ther. 2025;6:1002336
This article belongs to the special issue Use of Different Radiation Treatment Modalities in Cancer Therapy: The Role of Inflammation and Immune Response
Open Access
Correction
Correction: Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer
Abhishek Mahajan ... Kumar Prabhash
Published: July 08, 2024 Explor Target Antitumor Ther. 2024;5:800
Open Access
Systematic Review
The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review
Serin Moghrabi ... Akram Al-Ibraheem
Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002368
Open Access
Original Article
Survival prediction in triple-negative breast cancer: a Cox model with fairness assessment using ISO/IEC TR 24027:2021 in a MENA cohort
Mehrshad Alirezaei Farahani ... Marjan Mansourian
Published: March 20, 2026 Explor Target Antitumor Ther. 2026;7:1002362
Open Access
Original Article
Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition
Maellis Payet-Desruisseaux ... Borhane Annabi
Published: March 30, 2026 Explor Target Antitumor Ther. 2026;7:1002364
This article belongs to the special issue Novel Precision Medicine Approaches to Brain Tumors (Primary and Metastatic)
Open Access
Original Article
Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC
Yuki Oda ... Kiyohide Fujimoto
Published: April 13, 2026 Explor Target Antitumor Ther. 2026;7:1002365
Open Access
Protocol
Optimizing procedures for ocular radiation injury studies in the tree shrew
Lauren A. Dalvin ... Gavin W. Roddy
Published: December 01, 2025 Explor Target Antitumor Ther. 2025;6:1002352
Open Access
Editorial
The critical need for robust decision support in the era of precision cancer therapeutics
Maurie Markman
Published: January 22, 2026 Explor Target Antitumor Ther. 2026;7:1002356
Open Access
Original Article
CHD4 and NOX4 expression in thyroid tumor tissues
Salma Fenniche ... Rabii Ameziane El Hassani
Published: March 25, 2026 Explor Target Antitumor Ther. 2026;7:1002363
Open Access
Review
The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma
Alessia Ciafarone, Paola Palumbo
Published: May 21, 2026 Explor Target Antitumor Ther. 2026;7:1002374
This article belongs to the special issue Novel Precision Medicine Approaches to Brain Tumors (Primary and Metastatic)
Open Access
Letter to the Editor
Conceptualization of fibroblast growth factor receptor 1 targeting nanomedicines
Yilin Ma ... Zhengwei Huang
Published: December 17, 2025 Explor Target Antitumor Ther. 2025;6:1002353
Open Access
Retraction
Retraction: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
Editorial Office
Published: October 28, 2025 Explor Target Antitumor Ther. 2025;6:1002343
Open Access
Review
RNA therapeutic targeting of recalcitrant and rare cancers
Afeez Adekunle Ishola ... Bashir Lawal
Published: May 21, 2026 Explor Target Antitumor Ther. 2026;7:1002373
Open Access
Case Report
Solitary fibrous tumor of the lung: diagnostic challenges and surgical management
Vasileios Leivaditis ... Manfred Dahm
Published: April 21, 2026 Explor Target Antitumor Ther. 2026;7:1002367
Open Access
Original Article
Oligometastatic versus polymetastatic colon cancer: functional and genomic determinants of divergent metastatic trajectories
Roberto Sirica ... Alessandro Ottaiano
Published: May 13, 2026 Explor Target Antitumor Ther. 2026;7:1002371
Open Access
Review
More than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer
Luis Molina Calistro ... Yennyfer Arancibia
Published: July 06, 2026 Explor Target Antitumor Ther. 2026;7:1002377
This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches
Open Access
Systematic Review
Impact of smoking on subtypes and molecular profile of breast cancer: a systematic review
Georgia Ntella ... Athina Diamanti
Published: June 16, 2026 Explor Target Antitumor Ther. 2026;7:1002376
Open Access
Original Article
Oncologic outcome and safety profile of first-line enfortumab vedotin plus pembrolizumab vs. conventional chemotherapy in advanced urothelial cancer
Makito Miyake ... on behalf of the Nara Urological Research Treatment Group
Published: July 06, 2026 Explor Target Antitumor Ther. 2026;7:1002379
This article belongs to the special issue Emerging Innovation in Surgical and Medical Approaches on the Horizon for Urogenital Malignancies
Open Access
Review
Why precision oncology works: lessons from gastrointestinal stromal tumours
Si Ying Adelina Ho ... Vishal G Shelat
Published: July 06, 2026 Explor Target Antitumor Ther. 2026;7:1002378
This article belongs to the special issue Precision Oncology: Molecular Classification, Efficacy Prediction, and Treatment Decision-Making
Previous